Gene Therapy Review
Welcome to our gene therapy portal
The Gene Therapy Review is the web resource for patients and professionals interested in cell and gene therapy. Founded in 2008, the aim of the site is to be an information resource for basic and clinical research in the fields of gene therapy, cell therapy, and genetic vaccines, and to serve as a network in the exchange of information and news related to this arena. We welcome contributions from researchers and clinicians alike with a view in increase awareness in this vastly growing sector.
Gene Therapy in the News
A risk gene for dyslexia is associated with impairments in visual motion detection, according to a study. Mutations in the gene DCDC2 have previously been associated with dyslexia, and this study found that dyslexics with an altered copy of the gene are unable to detect certain types of visual motion.
A cluster of defined, non-coding RNAs are mechanistically involved in endocrine therapy resistance in human breast cancer cells, new research has revealed. Furthermore, resveratrol, a kind of polyphenol, was found to repress these RNAs and inhibit the proliferative activity of breast cancer cells which had acquired resistance.
Researchers have shown that changing just a single letter of the DNA of human red blood cells in the laboratory increases their production of oxygen-carrying hemoglobin -- a world-first advance that could lead to a cure for sickle cell anemia and other blood disorders. The new genome editing technique introduces a beneficial, naturally occurring genetic mutation into the cells to switch on a gene that is turned off in most people after birth.